Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19

MLA

Panda PK, et al. “Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19.” Clinical Pharmacology: Advances and Applications, vol. ume 13, Sept. 2021, pp. 185–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.f18526da9d24a08a14f2c889febc7a4&authtype=sso&custid=ns315887.

APA

Panda PK, Singh BO, Moirangthem B, Bahurupi YA, Saha S, Saini G, Dhar M, Bairwa M, Pai VS, Agarwal A, Sindhwani G, Handu S, & Kant R. (2021). Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19. Clinical Pharmacology: Advances and Applications, ume 13, 185–195.

Chicago

Panda PK, Singh BO, Moirangthem B, Bahurupi YA, Saha S, Saini G, Dhar M, et al. 2021. “Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19.” Clinical Pharmacology: Advances and Applications ume 13 (September): 185–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.f18526da9d24a08a14f2c889febc7a4&authtype=sso&custid=ns315887.